vaccine development

decision path change of plans arrows business decision
Biotech

Moderna's flu/COVID vaccine hit by deprioritization, FDA delay

Moderna is deprioritizing its flu/COVID combination vaccine in younger adults amid a push to cut about $1.5 billion from its operating expenses.
Nick Paul Taylor May 1, 2025 7:24am
Egg cartons sitting on grocery store shelf

HHS reevaluates $590M bird flu deal with Moderna: report

Feb 27, 2025 11:07am
Scientist in protective suit examining blood sample in lab

NIH grants up to $100M yearly for pandemic preparedness network

Sep 18, 2024 5:24pm
vaccine diversity flu covid shot needle

Vaxcyte surges on 'stunning' 31-valent PCV win against Pfizer

Sep 3, 2024 10:32am
virus pandemic pathogen global

Moderna joins 100 Days Mission to advance pandemic preparedness

Oct 30, 2023 9:21am
Merck Co

Chasing Moderna, Merck pays $50M to join emerging vaccine race

Mar 8, 2023 10:15am